OR-449

N/A

Report date: 2023/01/30 14:15:07
NME

Base Information

Drug NameOR-449
Drug Alias NameOR-449
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSteroidogenic factor 1 inhibitors
TargetsSteroidogenic factor 1
Therapy Area/IndicationsAdrenocortical Carcinoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesOrphagen Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsAdrenocortical Carcinoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A